Clinical trends for 2025: A year of change

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials.

Paving the road to functionally active antibody drugs

Antibody drugs have reshaped how we treat diseases.

The critical bioanalytical strategies unlocking the potentia...

Lipid nanoparticle (LNP) mRNA vaccines emerged during the COVID-19 pandemic to form an almost miraculous protection against a virus, which killed millions around the world.

‘Show me the molecule’ – On synthetic biology and cutting th...

Pharma 2025: AI, GLP-1 competition, and the future of clinic...

I’ve worked in clinical trials for twenty years. For most of that time, the core processes and challenges have been fairly consistent, with incremental improvements along the way.

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.